112 related articles for article (PubMed ID: 16522544)
41. FAS Haploinsufficiency Caused by Extracellular Missense Mutations Underlying Autoimmune Lymphoproliferative Syndrome.
de Bielke MG; Perez L; Yancoski J; Oliveira JB; Danielian S
J Clin Immunol; 2015 Nov; 35(8):769-76. PubMed ID: 26563159
[TBL] [Abstract][Full Text] [Related]
42. Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome.
Rao VK
Front Pediatr; 2015; 3():65. PubMed ID: 26258116
[TBL] [Abstract][Full Text] [Related]
43. Autoimmune Lymphoproliferative Syndrome (ALPS) in a Boy with Massive Lymphadenopathy.
Kianifar HR; Khalesi M; Farid R; Badiee Z; Rastin M; Ahanchian H
Iran J Allergy Asthma Immunol; 2010 Sep; 9(3):181-63. PubMed ID: 20952809
[TBL] [Abstract][Full Text] [Related]
44. Autoimmune Lymphoproliferative Syndrome Masquerading as Posttransplant Lymphoproliferative Disorder.
Jeffreys SM; Levy RA; Crary SE
J Pediatr Hematol Oncol; 2018 Jul; 40(5):e305-e308. PubMed ID: 28991130
[TBL] [Abstract][Full Text] [Related]
45. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease.
Bride K; Teachey D
F1000Res; 2017; 6():1928. PubMed ID: 29123652
[TBL] [Abstract][Full Text] [Related]
46. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
Cayrol J; Garrido Colino C
J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
[TBL] [Abstract][Full Text] [Related]
47. What's up in the ALPS.
Rieux-Laucat F
Curr Opin Immunol; 2017 Dec; 49():79-86. PubMed ID: 29073495
[TBL] [Abstract][Full Text] [Related]
48. Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II.
van der Werff ten Bosch J; Delabie J; Böhler T; Verschuere J; Thielemans K
Br J Haematol; 1999 Sep; 106(4):1045-8. PubMed ID: 10520011
[TBL] [Abstract][Full Text] [Related]
49. Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms.
Khanmohammadi S; Shabani M; Tabary M; Rayzan E; Rezaei N
Crit Rev Oncol Hematol; 2020 Jun; 150():102945. PubMed ID: 32353704
[TBL] [Abstract][Full Text] [Related]
50. Clinical, immunologic, and genetic characteristics of children with ALPS: A single-center experience.
Vanhye L; Bossuyt X; Meyts I; Bucciol G
Pediatr Allergy Immunol; 2023 Feb; 34(2):e13924. PubMed ID: 36825743
[No Abstract] [Full Text] [Related]
51. Autoimmunity and hematologic malignancies: associations and mechanisms.
Martin DN; Mikhail IS; Landgren O
Leuk Lymphoma; 2009 Apr; 50(4):541-50. PubMed ID: 19373651
[TBL] [Abstract][Full Text] [Related]
52. Historical review of lymphomas.
Aisenberg AC
Br J Haematol; 2000 Jun; 109(3):466-76. PubMed ID: 10886191
[No Abstract] [Full Text] [Related]
53. Clinical features and therapeutic challenges of cytopenias belonging to alps and alps-related (ARS) phenotype.
Palmisani E; Miano M; Micalizzi C; Calvillo M; Pierri F; Terranova P; Lanza T; Lanciotti M; Riccardi F; Todiere A; Zanardi S; Caviglia I; Dufour C; Fioredda F
Br J Haematol; 2019 Mar; 184(5):861-864. PubMed ID: 29527658
[No Abstract] [Full Text] [Related]
54. The Canale-Smith syndrome.
Straus SE; Lenardo M; Puck JM
N Engl J Med; 1997 May; 336(20):1457; author reply 1457-8. PubMed ID: 9148156
[No Abstract] [Full Text] [Related]
55. From the National Institutes of Health.
Raub W
JAMA; 1990 Nov; 264(17):2191. PubMed ID: 2214090
[No Abstract] [Full Text] [Related]
56. Charles E. Egwuagu: Going with the flow.
Houston S
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 33095234
[TBL] [Abstract][Full Text] [Related]
57. [Center for theStudy of the Occidental Alps, Torino].
Malaroda R
Ric Sci; 1970; 40(4):316-7. PubMed ID: 5500905
[No Abstract] [Full Text] [Related]
58. Autoimmune lymphoproliferative syndrome: an update and review of the literature.
Shah S; Wu E; Rao VK; Tarrant TK
Curr Allergy Asthma Rep; 2014 Sep; 14(9):462. PubMed ID: 25086580
[TBL] [Abstract][Full Text] [Related]
59. Autoimmune Lymphoproliferative Syndrome: An Overview.
Matson DR; Yang DT
Arch Pathol Lab Med; 2020 Feb; 144(2):245-251. PubMed ID: 30958694
[TBL] [Abstract][Full Text] [Related]
60. How I treat autoimmune lymphoproliferative syndrome.
Rao VK; Oliveira JB
Blood; 2011 Nov; 118(22):5741-51. PubMed ID: 21885601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
